miRagen raises $38.5M in follow-on

MicroRNA company miRagen Therapeutics Inc. (NASDAQ:MGEN) raised $38.5 million on Feb. 8 through the sale of 7 million shares at $5.50 in a follow-on underwritten by Jefferies, Evercore, Deutsche Bank, Wedbush and Oppenheimer...